2,100 Shares in The Clorox Company (NYSE:CLX) Purchased by Garrison Point Advisors LLC

Garrison Point Advisors LLC bought a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 2,100 shares of the company's stock, valued at approximately $341,000.

Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in Clorox by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock worth $2,518,517,000 after purchasing an additional 124,428 shares in the last quarter. State Street Corp increased its position in shares of Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Clorox by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company's stock valued at $501,925,000 after purchasing an additional 69,969 shares during the last quarter. Norges Bank acquired a new stake in shares of Clorox in the 4th quarter worth $259,041,000. Finally, Amundi grew its stake in Clorox by 42.6% during the 4th quarter. Amundi now owns 1,032,283 shares of the company's stock worth $165,816,000 after buying an additional 308,234 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

CLX stock traded up $0.81 during trading on Friday, hitting $141.71. 451,667 shares of the company traded hands, compared to its average volume of 1,290,990. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock's 50-day simple moving average is $147.53 and its 200 day simple moving average is $157.39. The company has a market cap of $17.46 billion, a PE ratio of 38.53, a P/E/G ratio of 2.62 and a beta of 0.61.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the firm posted $2.16 earnings per share. On average, equities analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.44%. Clorox's dividend payout ratio is currently 133.33%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CLX. StockNews.com cut Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Barclays lowered their target price on shares of Clorox from $140.00 to $139.00 and set an "underweight" rating for the company in a research note on Thursday, March 27th. DA Davidson cut their price target on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, Wells Fargo & Company dropped their price objective on shares of Clorox from $161.00 to $155.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 2nd. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $157.17.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.